Market Closed -
Xetra
11:35:01 2024-04-26 EDT
|
5-day change
|
1st Jan Change
|
151.8
EUR
|
+1.10%
|
|
+3.94%
|
+5.31%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
45,804
|
61,021
|
98,695
|
78,651
|
62,651
|
65,978
|
-
|
-
|
Enterprise Value (EV)
1 |
58,160
|
71,683
|
107,596
|
86,979
|
62,651
|
72,769
|
70,809
|
68,413
|
P/E ratio
|
34.7
x
|
30.7
x
|
32.3
x
|
23.6
x
|
22.2
x
|
22.2
x
|
18.9
x
|
16.9
x
|
Yield
|
1.23%
|
1%
|
0.81%
|
1.22%
|
-
|
1.52%
|
1.59%
|
1.65%
|
Capitalization / Revenue
|
2.84
x
|
3.48
x
|
5.01
x
|
3.54
x
|
2.98
x
|
3.11
x
|
2.93
x
|
2.8
x
|
EV / Revenue
|
3.6
x
|
4.09
x
|
5.47
x
|
3.91
x
|
2.98
x
|
3.42
x
|
3.15
x
|
2.9
x
|
EV / EBITDA
|
13.3
x
|
13.8
x
|
17.6
x
|
12.7
x
|
10.7
x
|
12.5
x
|
10.7
x
|
9.66
x
|
EV / FCF
|
28.5
x
|
34.7
x
|
30.3
x
|
31.9
x
|
-
|
28.4
x
|
24
x
|
20.5
x
|
FCF Yield
|
3.51%
|
2.88%
|
3.3%
|
3.14%
|
-
|
3.53%
|
4.17%
|
4.88%
|
Price to Book
|
2.56
x
|
3.59
x
|
4.63
x
|
3.03
x
|
-
|
2.28
x
|
2.09
x
|
1.93
x
|
Nbr of stocks (in thousands)
|
434,778
|
434,778
|
434,778
|
434,778
|
434,778
|
434,778
|
-
|
-
|
Reference price
2 |
105.4
|
140.4
|
227.0
|
180.9
|
144.1
|
151.8
|
151.8
|
151.8
|
Announcement Date
|
20-03-05
|
21-03-04
|
22-03-03
|
23-03-02
|
24-03-07
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
16,152
|
17,534
|
19,687
|
22,232
|
20,993
|
21,247
|
22,502
|
23,576
|
EBITDA
1 |
4,385
|
5,201
|
6,103
|
6,849
|
5,879
|
5,842
|
6,639
|
7,079
|
EBIT
1 |
2,120
|
2,985
|
4,179
|
4,474
|
3,609
|
3,881
|
4,564
|
5,028
|
Operating Margin
|
13.13%
|
17.02%
|
21.23%
|
20.12%
|
17.19%
|
18.27%
|
20.28%
|
21.33%
|
Earnings before Tax (EBT)
1 |
1,735
|
2,630
|
3,924
|
4,287
|
3,484
|
3,797
|
4,477
|
4,978
|
Net income
1 |
1,320
|
1,987
|
3,055
|
3,326
|
2,824
|
2,971
|
3,475
|
3,894
|
Net margin
|
8.17%
|
11.33%
|
15.52%
|
14.96%
|
13.45%
|
13.98%
|
15.44%
|
16.51%
|
EPS
2 |
3.040
|
4.570
|
7.030
|
7.650
|
6.490
|
6.821
|
8.034
|
8.972
|
Free Cash Flow
1 |
2,043
|
2,065
|
3,550
|
2,728
|
-
|
2,566
|
2,953
|
3,341
|
FCF margin
|
12.65%
|
11.78%
|
18.03%
|
12.27%
|
-
|
12.08%
|
13.13%
|
14.17%
|
FCF Conversion (EBITDA)
|
46.6%
|
39.7%
|
58.17%
|
39.83%
|
-
|
43.92%
|
44.48%
|
47.19%
|
FCF Conversion (Net income)
|
154.77%
|
103.9%
|
116.22%
|
82.02%
|
-
|
86.38%
|
85%
|
85.8%
|
Dividend per Share
2 |
1.300
|
1.400
|
1.850
|
2.200
|
-
|
2.311
|
2.420
|
2.503
|
Announcement Date
|
20-03-05
|
21-03-04
|
22-03-03
|
23-03-02
|
24-03-07
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
8,489
|
4,973
|
5,213
|
5,198
|
5,568
|
5,806
|
5,660
|
5,293
|
5,302
|
5,173
|
5,225
|
5,220
|
5,281
|
5,314
|
5,488
|
-
|
EBITDA
1 |
2,256
|
1,552
|
1,464
|
1,629
|
1,782
|
1,810
|
1,628
|
1,587
|
1,553
|
1,446
|
1,293
|
1,413
|
1,457
|
1,517
|
1,643
|
-
|
EBIT
1 |
-
|
1,047
|
1,039
|
1,173
|
1,177
|
1,234
|
889.6
|
1,035
|
969
|
983
|
621
|
777.4
|
826.2
|
1,095
|
1,015
|
-
|
Operating Margin
|
-
|
21.05%
|
19.93%
|
22.57%
|
21.14%
|
21.26%
|
15.72%
|
19.55%
|
18.28%
|
19%
|
11.89%
|
14.89%
|
15.65%
|
20.6%
|
18.49%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
993
|
991.9
|
1,139
|
1,122
|
1,187
|
839.1
|
1,012
|
894
|
937
|
641
|
754.7
|
801.1
|
1,070
|
982.5
|
-
|
Net income
1 |
-
|
761
|
802.1
|
880.4
|
867.1
|
923.2
|
655
|
796
|
704
|
739
|
586
|
676.2
|
720.6
|
824.9
|
818.9
|
-
|
Net margin
|
-
|
15.3%
|
15.39%
|
16.94%
|
15.57%
|
15.9%
|
11.57%
|
15.04%
|
13.28%
|
14.29%
|
11.22%
|
12.95%
|
13.65%
|
15.52%
|
14.92%
|
-
|
EPS
2 |
1.720
|
1.750
|
1.840
|
2.020
|
1.990
|
2.120
|
1.510
|
1.830
|
1.620
|
1.700
|
1.340
|
1.542
|
1.656
|
1.896
|
1.882
|
-
|
Dividend per Share
2 |
-
|
-
|
1.850
|
-
|
-
|
-
|
2.200
|
-
|
-
|
-
|
-
|
0.5500
|
0.5500
|
0.5500
|
0.5500
|
0.6000
|
Announcement Date
|
20-08-06
|
21-11-11
|
22-03-03
|
22-05-12
|
22-08-04
|
22-11-10
|
23-03-02
|
23-05-11
|
23-08-03
|
23-11-09
|
24-03-07
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
12,357
|
10,662
|
8,902
|
8,328
|
-
|
6,791
|
4,831
|
2,436
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.818
x
|
2.05
x
|
1.459
x
|
1.216
x
|
-
|
1.162
x
|
0.7277
x
|
0.3441
x
|
Free Cash Flow
1 |
2,043
|
2,065
|
3,550
|
2,728
|
-
|
2,566
|
2,953
|
3,341
|
ROE (net income / shareholders' equity)
|
13.8%
|
16.7%
|
19.8%
|
18.5%
|
-
|
12.8%
|
13.8%
|
13.8%
|
ROA (Net income/ Total Assets)
|
3.27%
|
4.64%
|
8.7%
|
9.31%
|
-
|
6.51%
|
7.36%
|
7.72%
|
Assets
1 |
40,348
|
42,804
|
35,111
|
35,718
|
-
|
45,611
|
47,194
|
50,423
|
Book Value Per Share
2 |
41.10
|
39.10
|
49.10
|
59.60
|
-
|
66.60
|
72.50
|
78.60
|
Cash Flow per Share
2 |
6.580
|
8.000
|
10.60
|
9.800
|
-
|
11.00
|
11.40
|
12.50
|
Capex
1 |
813
|
1,413
|
1,066
|
1,531
|
-
|
1,949
|
1,983
|
1,989
|
Capex / Sales
|
5.03%
|
8.06%
|
5.41%
|
6.89%
|
-
|
9.18%
|
8.81%
|
8.43%
|
Announcement Date
|
20-03-05
|
21-03-04
|
22-03-03
|
23-03-02
|
24-03-07
|
-
|
-
|
-
|
Last Close Price
151.8
EUR Average target price
182
EUR Spread / Average Target +19.93% Consensus |
1st Jan change
|
Capi.
|
---|
| +5.31% | 70.44B | | +10.97% | 8.94B | | -16.83% | 4.75B | | +43.48% | 4.5B | | +3.20% | 3.85B | | +18.82% | 2.38B | | -21.36% | 2.34B | | -29.67% | 2.2B | | +8.38% | 1.96B | | +3.90% | 1.65B |
Specialty & Advanced Pharmaceuticals
|